Erratum: Muscle disease (Pediatrics in Review (2014) 35, 2 (49-61) DOI: 10.1542/pir.35-2-49);Muscle disease

Pediatrics in Review

Volumn 35, Issue 2, 2014, Pages 49-60

  Tsao, Chang Yong ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DYSTROPHIN;

ARTICLE; BECKER MUSCULAR DYSTROPHY; CARNITINE DEFICIENCY; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; CRITICAL ILLNESS; DIFFERENTIAL DIAGNOSIS; DUCHENNE MUSCULAR DYSTROPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; ENDOCRINE MYOPATHY; EXON; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GASTROCNEMIUS MUSCLE; GENE DELETION; GLYCOGEN STORAGE DISEASE TYPE 2; HEREDITARY MUSCLE DISEASE; HUMAN; HYPERTROPHY; JUVENILE DERMATOMYOSITIS; JUVENILE POLYMYOSITIS; LABORATORY TEST; LIMB GIRDLE MUSCULAR DYSTROPHY; MITOCHONDRIAL ENCEPHALOMYOPATHY; MUSCLE DISEASE; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYASTHENIA GRAVIS; MYOPATHY; MYOSITIS; MYOTONIC DYSTROPHY; PEDIATRICIAN; PERIODIC PARALYSIS; PHYSICAL EXAMINATION; POLYMYOSITIS; THOMSEN DISEASE; TOXIC MYOPATHY; TRANSIENT NEONATAL MYASTHENIA GRAVIS; BLOOD; BRAIN; CASE REPORT; COMPLICATION; GENETICS; MALE; MUSCULAR DISEASES; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; PATHOLOGY; PRESCHOOL CHILD; SKELETAL MUSCLE;

BRAIN; CHILD, PRESCHOOL; CREATINE KINASE; DIAGNOSIS, DIFFERENTIAL; DYSTROPHIN; HUMANS; HYPERTROPHY; MALE; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION;

EID: 84893856596     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.35-3-137     Document Type: Erratum

References (22)

1. Mendell JR, Shilling C, Leslie ND, et al. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol. 2012;71(3):304-313
2. Bushby K, Finkel R, Birnkrant DJ, et al; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77-93
3. Darras BT, Miller DT, Urion DK. Dystrophinopathies. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, es. GeneReviews [Internet]. Seattle: University of Washington; 1993
4. Thrush PT, Allen HD, Viollet L, Mendell JR. Re-examination of the electrocardiogram in boys with Duchenne muscular dystrophy and correlation with its dilated cardiomyopathy. Am J Cardiol. 2009;103(2):262-265.
5. Viollet L, Thrush PT, Flanigan KM, Mendell JR, Allen HD. Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy. Am J Cardiol. 2012;110(1):98-102.
6. Hor KN, Wansapura J, Markham LW, et al. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol. 2009;53(14):1204-1210
7. Muntoni F. Cardiac complications of childhood myopathies. J Child Neurol. 2003;18(3):191-202 (Pubitemid 36527428)
8. Rosales XQ, al-Dahhak R, Tsao CY. Childhood onset of limbgirdle muscular dystrophy [published correction appears in Pediatr Neurol. 2013;48(6):483].
9. Pediatr Neurol. 2012;46(1):13-23
10. Nigro V, Aurino S, Piluso G. Limb girdle muscular dystrophies: update on genetic diagnosis and therapeutic approaches. Curr Opin Neurol. 2011;24(5):429-436
11. Mercuri E, Muntoni F. The ever-expanding spectrum of congenital muscular dystrophies. Ann Neurol. 2012;72(1):9-17
12. Richard JLF, Lemmers RJLF, Miller DG, van der Maarel SM. Facioscapulohumeral muscular dystrophy. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, eds. GeneReviews [Internet]. Seattle: University of Washington; 1993.
13. Tassin A, Laoudj-Chenivesse D, Vanderplanck C, et al. Article 1: DUX4 expression in FSHD muscle cells: how could such a rare protein cause myopathy? J Cell Mol Med. 2013;17(1):76-89.
14. Huber A, Feldman BM. An update on inflammatory myositis in children. Curr Opin Rheumatol. 2013;25(5):630-635 10.1097/BOR.0b013e3283635634
15. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet. 2008;371(9631):2201-2212 (Pubitemid 351890413)
16. Dalakas MC. Toxic and drug-induced myopathies. J Neurol Neurosurg Psychiatry. 2009;80(8):832-838
17. Moxley RT III, Ashwal S, Pandya S, et al; Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2005;64(1):13-20 (Pubitemid 40082930)
18. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2008; (1):CD003725
19. American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics. 2005;116(6):1569-1573
20. El-Hattab AE. Systemic primary carnitine deficiency. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, eds. GeneReviews [Internet]. Seattle: University of Washington; 1993-.
21. Sternberg D, Tabti N, Hainque B, Fontaine B. Hypokalemic periodic paralysis. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, eds. GeneReviews [Internet]. Seattle: University of Washington; 1993
22. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931-941